Diagnostic Tests/Kits Products & Reviews

Siemens Healthineers offers the ELF test to help improve the assessment of NAFLD/NASH and chronic liver disease patients at risk of disease progression.

Lab-based antigen testing for rapid virus detection: Time to first result in as little as 26 minutes.

Add confidence to screening and monitoring of monoclonal gammopathies. 

The IMMULITE® 2000/2000 XPi 3gAllergy™ Specific IgE assay helps to enhance patient care with reliable results from a simple blood test that uses quality extracts thoroughly evaluated for potency and allergenic composition. With the IMMULITE 2000/2000 XPi Immunoassay System, scaling your allergy and specialty test offerings feels routine. 

The Siemens Healthineers SCC assay, available on the Atellica ® IM Analyzer and ADVIA Centaur ® Immunoassay Systems, is a valuable tool for the assessment and monitoring of squamous cell carcinoma of the head and neck, lung, and cervix. Not available for sale in USA.

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.

Enzyme Immunoassay for the quantitative determination of Anti-Infliximab antibodies in human serum and plasma.

OXM causes weight loss via suppression of food intake and increase in energy expenditure. OXM administration was also reported to increase heart-rate in mice. Besides regulating glucose homeostasis in monogastric animals, OXM also increases the concentration of insulin and glucose in plasma of Holstein cattle under normal physiological conditions. It has been shown that Type 2 diabetes patients have lower levels of OXM and lev…

The Ansh Labs Bioactive IGF-I kit uses a highly sensitive two-site antibody method which allows detection of bioactive IGF-I. This assay enables accurate measurement and differentiation of bioactive IGF-I from total IGF-I levels. Assessment of bioactive to total IGF-I ratio will be informative and advance our understanding of IGF-I function and regulation in different physiological and disease states.

The Total IGF-I immunoassay is a direct detection method which eliminates potential altering of sample matrix from size-exclusion chromatography or filtration methods.